{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:59:27Z","timestamp":1790553567314,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-018-4022-5","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T14:39:43Z","timestamp":1518878383000},"page":"869-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Reactive arthritis: update 2018"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9214-2118","authenticated-orcid":false,"given":"A.","family":"Garc\u00eda-Kutzbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chac\u00f3n-S\u00fachite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Garc\u00eda-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Iraheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"issue":"4","key":"4022_CR1","first-page":"256","volume":"10","author":"Y Keynan","year":"2008","unstructured":"Keynan Y, Rimar D (2008) Reactive arthritis\u2014the appropriate name. Isr Med Assoc J 10(4):256\u2013258","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"4022_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/art.22374","volume":"56","author":"R Panush","year":"2007","unstructured":"Panush R, Wallace D, Dorff R, Engleman E (2007) Retraction of the suggestion to use the term \u00abReiter\u2019s syndrome\u00bb sixty-five years later. Arthritis Rheum 56(2):693\u2013694. https:\/\/doi.org\/10.1002\/art.22374","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4022_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jdv.12741","volume":"29","author":"P Stavropoulos","year":"2015","unstructured":"Stavropoulos P, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatology Venereol 29(3):415\u2013424. https:\/\/doi.org\/10.1111\/jdv.12741","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"3","key":"4022_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.berh.2011.01.018","volume":"25","author":"T Hannu","year":"2011","unstructured":"Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25(3):347\u2013357. https:\/\/doi.org\/10.1016\/j.berh.2011.01.018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"4022_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","volume":"17","author":"I Colmegna","year":"2004","unstructured":"Colmegna I, Cuchacovich R, Espinoza L (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17(2):348\u2013369. https:\/\/doi.org\/10.1128\/CMR.17.2.348","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"4022_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/1756-185X.12920","volume":"19","author":"R Gupta","year":"2016","unstructured":"Gupta R, Misra R (2016) Microbe-triggered arthropathies: reactive arthritis and beyond. Int J Rheum Dis 19(5):437\u2013439. https:\/\/doi.org\/10.1111\/1756-185X.12920","journal-title":"Int J Rheum Dis"},{"key":"4022_CR7","unstructured":"Lopez F\u00e9rez F, Garc\u00eda Novo E (1986) Tratados hipocr\u00e1ticos. (eds) Gredos, Madrid, Espa\u00f1a"},{"issue":"8207","key":"4022_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(80)92381-8","volume":"316","author":"D Allison","year":"1980","unstructured":"Allison D (1980) Christopher Columbus: first case of Reiter\u2019S disease in the old world? Lancet 316(8207):1309. https:\/\/doi.org\/10.1016\/S0140-6736(80)92381-8","journal-title":"Lancet"},{"issue":"1","key":"4022_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.rdc.2009.03.010","volume":"35","author":"J Carter","year":"2009","unstructured":"Carter J, Hudson A (2009) Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am 35(1):21\u201344. https:\/\/doi.org\/10.1016\/j.rdc.2009.03.010","journal-title":"Rheum Dis Clin N Am"},{"key":"4022_CR10","doi-asserted-by":"publisher","unstructured":"Manasson J, Shen N, Garc\u00eda H, Ubeda C, Iraheta I, Heguy A, Von Feldt J, Espinoza L, Garc\u00eda Kutzbach A, Segal L, Ogdie A, Clemente J, Sher J (2017) Gut microbiota perturbations in reactive arthritis and post-infectious Spondyloarthritis arthritis. Rheum. https:\/\/doi.org\/10.1002\/art.40359 [Epub ahed of print]","DOI":"10.1002\/art.40359"},{"issue":"5","key":"4022_CR11","doi-asserted-by":"publisher","first-page":"A325","DOI":"10.1016\/j.autrev.2009.11.012","volume":"9","author":"M Ehrenfeld","year":"2010","unstructured":"Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9(5):A325\u2013A329. https:\/\/doi.org\/10.1016\/j.autrev.2009.11.012","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4022_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/tre.501","volume":"7","author":"S Szamocki","year":"2016","unstructured":"Szamocki S, Martyn-hemphill C, Green J (2016) Reactive arthritis: can\u2019t see, can\u2019t pee, can\u2019t climb a tree. Trends Urol Men\u2019s Heal 7(1):17\u201320. https:\/\/doi.org\/10.1002\/tre.501","journal-title":"Trends Urol Men\u2019s Heal"},{"issue":"4","key":"4022_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MAJ.0b013e31820f8cf1","volume":"341","author":"A Garc\u00eda-Kutzbach","year":"2011","unstructured":"Garc\u00eda-Kutzbach A, Montenegro A, Iraheta I, Bar\u00e1 C, Sa\u00e9nz R (2011) Epidemiology of spondyloarthropathies in Central America. Am J Med Sci 341(4):295\u2013297. https:\/\/doi.org\/10.1097\/MAJ.0b013e31820f8cf1","journal-title":"Am J Med Sci"},{"issue":"7809","key":"4022_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"301","author":"D Brewerton","year":"1973","unstructured":"Brewerton D, Hart F, Nicholls A, Caffrey M, James D, Sturrock R (1973) Ankylosing spondylitis and HlA 27. Lancet 301(7809):904\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(73)91360-3","journal-title":"Lancet"},{"issue":"14","key":"4022_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJM197304052881403","volume":"288","author":"L Schlosstein","year":"1973","unstructured":"Schlosstein L, Terasaki P, Bluestone R, Pearson C (1973) High association of an HLA antigen, W27 with ankylosing spondylitis. N Engl J Med 288(14):704\u2013705. https:\/\/doi.org\/10.1056\/NEJM197304052881403","journal-title":"N Engl J Med"},{"issue":"10","key":"4022_CR16","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.4049\/jimmunol.172.10.6202","volume":"172","author":"A Vazquez-Torres","year":"2004","unstructured":"Vazquez-Torres A, Vallance B, Bergman M, Finlay B, Cookson B, Jones-Carson J et al (2004) Toll-like receptor 4 dependence of innate and adaptive immunity to salmonella: importance of the Kupffer cell network. J Immunol 172(10):6202\u20136208. https:\/\/doi.org\/10.4049\/jimmunol.172.10.6202","journal-title":"J Immunol"},{"issue":"6","key":"4022_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10067-014-2662-7","volume":"33","author":"JD Reveille","year":"2014","unstructured":"Reveille JD (2014) An update on the contribution of the MHC to as susceptibility. Clin Rheumatol 33(6):749\u2013757. https:\/\/doi.org\/10.1007\/s10067-014-2662-7","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4022_CR18","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.23967","volume":"58","author":"F Tsui","year":"2008","unstructured":"Tsui F, Xi N, Rohekar S, Riarh R, Bilotta R, Tsui H et al (2008) Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58(11):3436\u20133438. https:\/\/doi.org\/10.1002\/art.23967","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4022_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.berh.2006.08.008","volume":"20","author":"M Rihl","year":"2006","unstructured":"Rihl M, Klos A, K\u00f6hler L, Kuipers J (2006) Reactive arthritis. Best Pract Res Clin Rheumatol 20(6):1119\u20131137. https:\/\/doi.org\/10.1016\/j.berh.2006.08.008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"4022_CR20","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s10067-016-3364-0","volume":"35","author":"H Denison","year":"2016","unstructured":"Denison H, Curtis E, Clynes M, Bromhead C, Dennison E, Grainger R (2016) The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol 35(11):2639\u20132648. https:\/\/doi.org\/10.1007\/s10067-016-3364-0","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4022_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/BOR.0000000000000299","volume":"28","author":"M Asquith","year":"2016","unstructured":"Asquith M, Rosenbaum J (2016) The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. Curr Opin Rheumatol 28(4):405\u2013412. https:\/\/doi.org\/10.1097\/BOR.0000000000000299","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"4022_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","volume":"8","author":"JD Reveille","year":"2012","unstructured":"Reveille JD (2012) Genetics of spondyloarthritis\u2014beyond the MHC. Nat Rev Rheumatol 8(5):296\u2013304. https:\/\/doi.org\/10.1038\/nrrheum.2012.41","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4022_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2006.12.006","volume":"37","author":"J Pope","year":"2007","unstructured":"Pope J, Krizova A, Garg A, Thiessen-Philbrook H, Ouimet J (2007) Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37(1):48\u201355. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.12.006","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4022_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/microorganisms4030030","volume":"4","author":"H Zeidler","year":"2016","unstructured":"Zeidler H, Hudson A (2016) Coinfection of chlamydiae and other bacteria in reactive arthritis and spondyloarthritis: need for future research. Microorganisms 4(3):30. https:\/\/doi.org\/10.3390\/microorganisms4030030","journal-title":"Microorganisms"},{"issue":"3","key":"4022_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.berh.2011.05.001","volume":"25","author":"J Carter","year":"2011","unstructured":"Carter J, Inman R (2011) Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol 25(3):359\u2013374. https:\/\/doi.org\/10.1016\/j.berh.2011.05.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"4022_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/ard.2004.030395","volume":"64","author":"J Gaston","year":"2005","unstructured":"Gaston J (2005) Shigella induced reactive arthritis. Ann Rheum Dis 64(4):517\u2013518. https:\/\/doi.org\/10.1136\/ard.2004.030395","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4022_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4236\/ijcm.2013.412A2004","volume":"4","author":"E Cargnelutti","year":"2013","unstructured":"Cargnelutti E, Di Genaro M (2013) Reactive arthritis: from clinical features to pathogenesis. Int J Clin Med 4(12):20\u201330. https:\/\/doi.org\/10.4236\/ijcm.2013.412A2004","journal-title":"Int J Clin Med"},{"key":"4022_CR28","doi-asserted-by":"publisher","unstructured":"Garcia H, Azan A, Iraheta I, Von Feldt J, Espinoza L, Manasson J, Scher J, Garc\u00eda Kutzbach A (2017) Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-017-3911.3 [Epub ahed of print]","DOI":"10.1007\/s10067-017-3911.3"},{"issue":"7","key":"4022_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrrheum.2016.85","volume":"12","author":"T Van de Wiele","year":"2016","unstructured":"Van de Wiele T, Van Praet J, Marzorati M, Drennan M, Elewaut D (2016) How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12(7):398\u2013411. https:\/\/doi.org\/10.1038\/nrrheum.2016.85","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"4022_CR30","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s10067-017-3875-3","volume":"36","author":"A Caminer","year":"2017","unstructured":"Caminer A, Haberman R, Scher J (2017) Human microbiome, infections, and rheumatic disease. Clin Rheumatol 36(12):2645\u20132653. https:\/\/doi.org\/10.1007\/s10067-017-3875-3","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4022_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","volume":"66","author":"J Brown","year":"2015","unstructured":"Brown J, Hazen S (2015) The gut microbial endocrine organ: bacterially-derived signals driving cardiometabolic diseases. Annu Rev Med 66(1):343\u2013359. https:\/\/doi.org\/10.1146\/annurev-med-060513-093205","journal-title":"Annu Rev Med"},{"issue":"5728","key":"4022_CR32","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"P Eckburg","year":"2005","unstructured":"Eckburg P, Bik E, Bernstein C, Purdom E, Dethlefsen L, Sargent M, Gill S, Nelson K, Relman D (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635\u20131638. https:\/\/doi.org\/10.1126\/science.1110591","journal-title":"Science"},{"issue":"3","key":"4022_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrmicro2973","volume":"11","author":"M Blaser","year":"2013","unstructured":"Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11(3):213\u2013217. https:\/\/doi.org\/10.1038\/nrmicro2973","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"4022_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/rheumatology\/keu469","volume":"55","author":"A Catrina","year":"2016","unstructured":"Catrina A, Deane K, Scher J (2016) Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology 55(3):391\u2013402. https:\/\/doi.org\/10.1093\/rheumatology\/keu469","journal-title":"Rheumatology"},{"key":"4022_CR35","doi-asserted-by":"publisher","unstructured":"Wendling D, Prati C (2017) Spondyloarthritis: an expanding cast of cellular actors. Jt bone Spine:1\u20133. https:\/\/doi.org\/10.1016\/j.jbspin.2017.05","DOI":"10.1016\/j.jbspin.2017.05"},{"issue":"2","key":"4022_CR36","first-page":"90","volume":"64","author":"A Ericsson","year":"2014","unstructured":"Ericsson A, Hagan C, Davis D, Franklin C (2014) Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med 64(2):90\u201398","journal-title":"Comp Med"},{"key":"4022_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/AGG.S57215","volume":"5","author":"B Ji","year":"2015","unstructured":"Ji B, Nielsen J (2015) New insight into the gut microbiome through metagenomics. Adv Genomics Genet 5:77\u201391. https:\/\/doi.org\/10.2147\/AGG.S57215","journal-title":"Adv Genomics Genet"},{"issue":"3","key":"4022_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"I Ivanov","year":"2009","unstructured":"Ivanov I, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485\u2013498. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033","journal-title":"Cell"},{"issue":"1","key":"4022_CR39","doi-asserted-by":"publisher","first-page":"e000284","DOI":"10.1136\/rmdopen-2016-000284","volume":"3","author":"P Miossec","year":"2017","unstructured":"Miossec P (2017) Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD 3(1):e000284. https:\/\/doi.org\/10.1136\/rmdopen-2016-000284","journal-title":"RMD"},{"issue":"3","key":"4022_CR40","first-page":"349","volume":"25","author":"L Riente","year":"2007","unstructured":"Riente L, Sedie A, Filippucci E, Iagnocco A, Meenagh G, Grassi W, Valesini G, Bombardieri S (2007) Ultrasound imaging for the rheumatologist IX. Ultrasound imaging in spondyloarthritis. Clin Exp Rheumatol 25(3):349\u2013353","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4022_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11926-996-0040-4","volume":"7","author":"I Colmegna","year":"2005","unstructured":"Colmegna I, Espinoza L (2005) Recent advances in reactive arthritis. Curr Rheumatol Rep 7(3):201\u2013207. https:\/\/doi.org\/10.1007\/s11926-996-0040-4","journal-title":"Curr Rheumatol Rep"},{"key":"4022_CR42","doi-asserted-by":"publisher","unstructured":"Allen-Vercoe E, Reid G, Viner N, Gloor G, Hota S, Kim P, Lee C, O\u2019Doherty K, Vanner S, Weewe S, Petrof E (2012) A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26(7):457\u2013462. https:\/\/doi.org\/10.1155\/2012\/213828","DOI":"10.1155\/2012\/213828"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-018-4022-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:53:20Z","timestamp":1659059600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-018-4022-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4022"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4022-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Abraham Garcia-Kutzbach: serve as Principal Investigator for clinical studies of Merck, Abbie, Novartis, and JanssenHelga Garcia: Medical Scientific Liaison for Novartis Pharma Central America and CaribbeanJose A. Chacon and Isa Iraheta do not report conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}